Home
Matrix Capital Management Company reported a 5.7% stake in Maze Therapeutics MAZE · 2,486,184 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.7%
- Last report
- First report
- Shares held
- 2,486,184 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 25/03/31
- Filed
- 25/05/14
First 5%+ report · 5.7% stake
Maze Therapeutics trades, last 26 weeks
What else happened in Maze Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Matrix Capital Management Company's other 5% stake reports
- Matrix Capital Management Company
5% stakeAura Biosciences
5% stakeAura Biosciences
AURA
0% stake
0 sh
0% stake
Filed 05/11
- Matrix Capital Management Company
5% stakeZentalis Pharmaceuticals
5% stakeZentalis Pharmaceuticals
ZNTL
0% stake
0 sh
0% stake
Filed 01/02
- Matrix Capital Management Company
5% stakeZentalis Pharmaceuticals
5% stakeZentalis Pharmaceuticals
ZNTL
9.98% stake
6,459,973 sh
9.98% stake
Filed 25/12/15
- Matrix Capital Management Company
5% stakeMaze Therapeutics
5% stakeMaze Therapeutics
MAZE
3.5% stake
1,653,684 sh
3.5% stake
Filed 25/11/13
- Matrix Capital Management Company
5% stakeAura Biosciences
5% stakeAura Biosciences
AURA
11.17% stake
6,922,870 sh
11.17% stake
Filed 25/05/19
